ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 1220 • ACR Convergence 2022

    Autonomic Dysfunction in Sjogren’s Disease

    Ardy Fenando1, Jordan Estes1, Maha Mohamad1, Sareena Shah2, John Lee2, Duaa Jabari1, Joshua Baker3 and Ghaith Noaiseh1, 1University of Kansas Medical Center, Kansas City, KS, 2University of Missouri-Kansas City, Kansas City, MO, 3University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Sjogren's Disease (SjD) is a heterogenous autoimmune disease associated with debilitating symptoms. Autonomic dysfunction (AD) is common in SjD and may contribute to symptom…
  • Abstract Number: 1221 • ACR Convergence 2022

    Multi-Center Validation of Cell-Bound Complement Activation Products and a Multianalyte Assay Panel Distinguishing Systemic Lupus Erythematosus from Primary Fibromyalgia

    Mark Rudolph1, Scott Rey1, Alan Kivitz2, Stuart Silverman3, Roland Staud4 and Roberta Alexander1, 1Exagen, Inc., Vista, CA, 2Department of Rheumatology, Altoona Center for Clinical Research, Duncansville, PA, 3Cedars-Sinai Medical Center, Los Angeles, CA, 4University of Florida, Gainesville, FL

    Background/Purpose: A 2016 article in Lupus Science & Medicine (Wallace et al. 2016) described the ability of cell-bound complement activation products (CB-CAPs) on their own--…
  • Abstract Number: 1222 • ACR Convergence 2022

    Association of Fibromyalgia, PTSD and Combat Deployments in Active Duty Military

    James Dizmang1 and Jeanne Tofferi2, 1US Air Force, Vacaville, CA, 2US Army, Ft Sam Houston, TX

    Background/Purpose: Many combat veterans experience unexplained symptoms with long-term disability including chronic pain, irritability, headaches, fatigue, behavioral health conditions, and memory difficulty. These invisible wounds…
  • Abstract Number: 1224 • ACR Convergence 2022

    ‘No Route Map’: The Complex Healthcare Journeys of People with Fibromyalgia – a Record Linkage Study in the UK

    Rosemary Hollick, Ka-Kin Lam, Marcus Beasley, Gareth Jones, Corri Black and Gary Macfarlane, University of Aberdeen, Aberdeen, Scotland, United Kingdom

    Background/Purpose: Healthcare services for persons with fibromyalgia (FM) lack co-ordination. Patients describe feeling 'invisible' within healthcare systems and often report poor experiences of care, particularly…
  • Abstract Number: 1225 • ACR Convergence 2022

    Sphygmomanometry for Fibromyalgia Detection in a Rheumatology Outpatient Clinic. a Cross-sectional Study

    Viridiana Del Río Guerrero1, Laura Aline Martínez Martínez1, Karina Arias Callejas1, Natalia Carbonell-Bobadilla2, Alejandra Mejía Segura1, Gibrán Azamar Morales1, Alejandra Espinosa Orantes1, Mauricio Mora Ramírez1, Fernanda Mejía Ávila1, Raúl Molina Sánchez1, Angélica Vargas-Guerrero1, Luis H Silveira1 and Manuel Martínez-Lavín3, 1Instituto Nacional de Cardiología, Ciudad de México, Mexico, 2National Institute of Cardiology Ignacio Chávez, Ciudad de México, Mexico, 3Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico

    Background/Purpose: Allodynia is a key fibromyalgia (FM) feature. Women suffering from FM display more often sphygmomanometry-elicited allodynia when compared to women with osteoarthritis, rheumatoid arthritis…
  • Abstract Number: 0477 • ACR Convergence 2021

    TNX-102 SL (Sublingual Cyclobenzaprine) for the Treatment of Fibromyalgia in the RELIEF Study: Positive Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Trial

    Gregory Sullivan1, Mary Kelley2, Annabelle Iserson1, Perry Peters2, Ashild Peters2, Candace Flint1, Judy Gendreau3, Herb Harris1, Ben Vaughn4 and Seth Lederman5, 1Tonix Pharmaceuticals, Inc., Chatham, NJ, 2Tonix Pharmaceuticals, Inc., San Diego, CA, 3Gendreau Consulting, LLC, Poway, CA, 4Rho, Inc., Cary, NC, 5Tonix Pharmaceuticals, Inc., South Dartmouth, MA

    Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain, fatigue, and nonrestorative sleep, a symptom constellation suggestive of a pathological disturbance in central pain processing…
  • Abstract Number: 0659 • ACR Convergence 2021

    Understanding the Rheumatologic Population We Serve Through Objective Analysis of Referrals and Diagnoses: Does Perception Match Actual Data?

    Kirsten Koons1, Jonida Cote2, Sanjeev Shrestha3, Melissa Band3, David Pugliese4 and Eric Newman3, 1Geisinger Medical Center, Lewisburg, PA, 2Geisinger Medical Center, Orefield, PA, 3Geisinger Medical Center, Danville, PA, 4Geisinger Medical Center, Wilkes Barre, PA

    Background/Purpose: Healthcare access in our Rheumatology Department is challenging. Fibromyalgia is perceived to occupy a large portion of clinic visits, leading to increased wait times…
  • Abstract Number: 0748 • ACR Convergence 2021

    Performance of Standardized Scores for Disease Assessment and Pain in Patients Withspondyloarthritis and Fibromyalgia

    Xenofon Baraliakos, Styliani Tsiami, Maria Claudia Gkelaki, Piet Dukatz, Uta Kiltz and Jürgen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: The pathogenesis of spondyloarthritis (SpA) including axial SpA (axSpA) and psoriatic arthritis (PsA) differs from fibromyalgia (FM). However, symptoms partially overlap and both patient…
  • Abstract Number: 0872 • ACR Convergence 2021

    Lack of Association Between Cognitive Test Performance and Cognitive Symptoms in Systemic Lupus Erythematosus (SLE)

    Sudha Raghunath1, Yifat Glikmann-Johnston1, Emma Guymer1, Eric Morand2, Julie Stout1 and Alberta Hoi3, 1Monash University, Melbourne, Australia, 2School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia, 3Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia

    Background/Purpose: Cognitive dysfunction (CD) is reported to affect approximately 40% of SLE patients (1). Mood disorders have been associated with both cognitive symptoms and cognitive…
  • Abstract Number: 0118 • ACR Convergence 2021

    Multidimensional Phenotypes of Sleep Quality Using the Pittsburg Quality Sleep Index and Associations Among Sleep Dimensions and Symptoms in Women Diagnosed with Fibromyalgia

    Victoria Menzies, Debra Lynch Kelly and Miichael Weaver, University of Florida, Gainesville, FL

    Background/Purpose: There are over 10 million people in the United States suffering with fibromyalgia syndrome (FMS). Individuals with FMS typically report multiple concurrent symptoms including…
  • Abstract Number: 0119 • ACR Convergence 2021

    Worsened Depression but Improved Fatigue Were the Main Impacts of Severe Lockdown in Non- COVID Infected Australian Fibromyalgia Patients

    Benjamin Worcester1, Emma Guymer2 and Geoffrey Littlejohn2, 1Monash Health, Melbourne, Australia, 2Monash University, Melbourne, Australia

    Background/Purpose: To gauge the impact of severe COVID-19 related lockdown restrictions on the mental and physical wellbeing of Australian fibromyalgia patients and their recovery following…
  • Abstract Number: 0120 • ACR Convergence 2021

    Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis

    Beth Wallace1, Meriah Moore2, Andrew Heisler3, Lutfiyya Muhammad4, Jing Song5, Daniel Clauw2, Clifton Bingham6, Marcy Bolster7, Wendy Marder2, Tuhina Neogi8, Alyssa Wohlfahrt9, Dorothy Dunlop10 and Yvonne Lee10, 1Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI, 3Bronson Rheumatology Specialists, Kalamazoo, MI, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5Northwestern University, Worthington, IL, 6Johns Hopkins University, Baltimore, MD, 7Massachusetts General Hospital, Boston, MA, 8Boston University School of Medicine, Boston, MA, 9Tufts University School of Medicine, Boston, MA, 10Northwestern University, Chicago, IL

    Background/Purpose: Over one-third of patients with rheumatoid arthritis (RA) exhibit evidence of fibromyalgianess, a cluster of somatic symptoms associated with increased sensitivity to painful stimuli.…
  • Abstract Number: 0121 • ACR Convergence 2021

    The Efficacy of Group Behavioral Activation versus Usual Treatment in Patients with Fibromyalgia and Major Depression

    Josefina Duran, Alvaro Verges, Ana Rocío Vázquez-Taboada, Matias Gonzalez and Lydia Gomez-Pérez, Pontificia Universidad Católica de Chile, Santiago, Chile

    Background/Purpose: Fibromyalgia (FM) and major depression frequently coexist. Patients with both conditions have a worse prognosis and higher disability, and their treatment options are scarce.…
  • Abstract Number: 0122 • ACR Convergence 2021

    Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial

    Stephanie Catella1, Michael Gendreau2, Nicolette Vega1, Allison Kraus1, Michael Rosenbluth1, Sherry Soefje3, Shishuka Malhotra4 and Lesley Arnold5, 1Swing Therapeutics, San Francisco, CA, 2Gendreau Consulting, LLC, Poway, CA, 3Excell Research, Oceanside, CA, 4Neuro-Behavioral Clinical Research, North Canton, OH, 5University of Cincinnati, Cincinnati, OH

    Background/Purpose: Recommendations for fibromyalgia management include both pharmacologic and nonpharmacologic treatments. Cognitive behavioral therapy (CBT) has demonstrated level 1A evidence for fibromyalgia management, though access…
  • Abstract Number: 0123 • ACR Convergence 2021

    Vestibulocortical Stimulation with Caloric Irrigation Reduces Pain and Improves Subjective Well-Being in Fibromyalgia: An Open-Label Pilot Trial

    Michael Kaplan1, Celine Zhou1, Emily Carroll1, Alan Weinberg2, Daniel Clauw3, Trung Thanh Ngo4 and Ioannis Tassiulas5, 1The Mount Sinai Hospital, Manhattan, NY, 2The Mount Sinai Hospital, New York, NY, 3University of Michigan, Ann Arbor, MI, 4University of Queensland & Translational Research Institute, Woolloongabba, Australia, 5Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Safe and effective therapies for fibromyalgia (FM) remain a major unmet clinical need. Vestibulocortical stimulation (VCS) via caloric irrigation is a safe, inexpensive, non-invasive…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology